Advertisements



Sell Biogen Going Into Its Aducanumab BLA Filing

Sell Biogen Going Into Its Aducanumab BLA Filing.....»»

Category: topSource: seekingalphaNov 8th, 2019

Some Biogen Analysts Unimpressed By Explanation For Aducanumab Filing Delay

Biogen Inc (NASDAQ: BIIB) shares shed close to 10% Wednesday following the revelation that the BLA filing for the company's Alzheimer's invest Latest R.....»»

Category: blogSource: benzingaApr 23rd, 2020

Citi downgrades Biogen to Sell, dissatisfied with filing delay response

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 23rd, 2020

Biogen sees completing U.S. filing for Alzheimer"s drug aducanumab in Q3

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 22nd, 2020

Biogen"s Alzheimer"s Drug "Falls Far Short Of Compelling Argument For Approval," Baird Says In Downgrade

Biogen Inc (NASDAQ: BIIB) shares gained more than 25% earlier this year when the company said it planned a regulatory filing for its Alzheimer's drug aducanumab fo Latest Ratings for BIIB DateFirmAc.....»»

Category: blogSource: benzingaDec 2nd, 2019

Biogen Analysts Debate About-Face On Aducanumab: "Path To Market An Uphill Battle"

Biogen Inc (NASDAQ: BIIB) shares rallied strongly Tuesday after the biotech said it plans a regulatory filing for its Alzheimer's d.....»»

Category: blogSource: benzingaOct 23rd, 2019

Shares of Japan"s Eisai swamped with sell orders after ending Alzheimer trials

Eisai Co Ltd's shares were untraded on Friday, hit with a glut of sell orders after the Japanese drugmaker and its partner Biogen Inc said they are ending two drug trials of their experimental Alzheimer's disease drug aducanumab......»»

Category: topSource: reutersMar 21st, 2019

Moderna drops 4% to $76.86 after filing to sell $1.25B of shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2020

Three more KC-area retail stores may become a victim of Covid-19 pandemic

Houston-based Stage Stores Inc. (NYSE: SSI), which owns several department store brands, has filed for Chapter 11 bankruptcy protection and is looking to sell its business. The bankruptcy filing, which was anticipated as early as February, comes les.....»»

Category: topSource: bizjournalsMay 11th, 2020

Southwest to raise $815 million through sale and leaseback of 20 planes

Southwest Airlines Co will sell and lease back 20 planes for gross proceeds of about $815 million, the company said in a regulatory filing on Friday......»»

Category: topSource: reutersMay 8th, 2020

Magellan Health to sell off key business unit to California company in $850M deal

Scottsdale managed care giant Magellan Health Inc. said Thursday it had entered into a definitive agreement to sell one of national business units to a California company. Magellan Health (Nasdaq: MGLN) said in a regulatory filing that it has agreed to.....»»

Category: topSource: bizjournalsApr 30th, 2020

Biogen may lack catalysts until more aducanumab clarity, says Jefferies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 23rd, 2020

Biogen filing delay "insignificant" versus bigger picture, says H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 23rd, 2020

Biogen downgraded to Sell from Neutral at Citi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 23rd, 2020

Biogen has initiated re-dosing study for aducanumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 22nd, 2020

Novavax sinks 16% after filing to sell up to $150M of shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 2nd, 2020

Bankrupt Boy Scouts may need to sell Norman Rockwell art to pay sexual abuse victims

Buried in the Boy Scouts' bankruptcy filing is a mention of a lucrative asset: original Norman Rockwell paintings. Should they be sold t.....»»

Category: topSource: usatodayFeb 27th, 2020

Tesla Prices 2.65M-Share Offering At $767

Tesla Inc. (NASDAQ: TSLA) said in a filing with the Securities and Exchange Commission that it plans to sell 2.65 million shares priced at $767 each, raising around $2.03 billion in to read more.....»»

Category: blogSource: benzingaFeb 14th, 2020

SVB Leerink stays bullish on Biogen"s aducanumab under new analyst

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 4th, 2020

Biogen CEO: "Excited about the prospects for aducanumab in Alzheimer"s disease"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 30th, 2020

Aducanumab Data A Positive For Biogen Regardless Of FDA Approval Timeline

Aducanumab Data A Positive For Biogen Regardless Of FDA Approval Timeline.....»»

Category: topSource: seekingalphaDec 12th, 2019